Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
05/2012
05/23/2012EP2241569B1 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
05/23/2012CN102471307A 噻吩衍生物及其制造方法、噻吩衍生物的聚合物 Thiophene derivative and its manufacturing method, a polymer of thiophene derivatives
05/23/2012CN102464667A 一类五元杂环并嘧啶类化合物及其制备方法和用途 A class of five-membered heterocyclic pyrimidine compounds and their preparation and use
05/23/2012CN101870703B Linked disulfide propyl porphyrin and metal complex, preparation method and application thereof
05/23/2012CN101687883B Modulators of cystic fibrosis transmembrane conductance regulator
05/23/2012CN101528753B Novel fused-ring aromatic compound, process for producing the same, and use thereof
05/22/2012US8183375 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/22/2012US8183246 Acyclically substituted furopyrimidine derivatives and use thereof
05/18/2012WO2012065139A2 Entpd5 inhibitors
05/18/2012WO2012063753A1 Indole compound, photoelectric conversion pigment using same, semiconductor electrode, photoelectric conversion element, and photoelectrochemical cell
05/18/2012WO2012062044A1 Small molecule inhibitor syntelin against kinetochore motor protein cenp-e and use thereof
05/18/2012WO2012062036A1 Preparation method and applications of a two-ring intermediate including a penem-type side chain
05/18/2012WO2012027348A3 Substituted 3,4-propylenedioxythiophene monomers and 3,4-propylenedioxythiophene-based crosslinkers and polymers thereof
05/17/2012US20120122943 Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents
05/17/2012US20120122891 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
05/17/2012US20120122890 Potassium Channel Modulators
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122860 Solid forms of sulfonamides and amino acids
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120119195 Novel organic semiconductive material and electronic device using the same
05/17/2012US20120119157 Thiophene derivative, method for producing same, and polymer of thiophene derivative
05/16/2012EP2453496A1 Organic electroluminescent element, novel compound, lighting device and display device
05/16/2012EP2452942A1 Substituted benzochalcogenoacene compound, thin film comprising the compound, and organic semiconductor device including the thin film
05/16/2012EP2451816A1 Crystalline form of prasugrel hydrobromide, preparation and application thereof
05/16/2012EP2451811A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
05/16/2012CN1931827B 2- and 2,5-substituted phenylketo-enols
05/16/2012CN102459280A 作为病毒复制抑制剂的噻吩并[2,3-b]吡啶衍生物 As inhibitors of viral replication thieno [2,3-b] pyridine derivatives
05/16/2012CN102459277A Substituted pyrazine (thio)pyrans with a herbicidal action
05/16/2012CN102459251A 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物 Compound bicyclic heteroaryl moiety having two fused leukotriene a4 hydrolase as modulators of
05/16/2012CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method
05/16/2012CN102459230A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102453228A Organic semiconductor material containing fluorene, anthracene and benzodithiophene units, preparation method, and application thereof
05/15/2012US8178545 Dual small molecule inhibitors of cancer and angiogenesis
05/15/2012CA2518620C 2,4,6-phenyl substituted cyclic ketoenols
05/10/2012WO2012060460A1 Substituted chalcogeno-acene compound
05/10/2012WO2012059041A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/10/2012WO2012019426A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115851 Compound inhibiting in vivo phosphorus transport and medicine containing the same
05/10/2012US20120115726 Herbicidal compounds
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120112174 Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode
05/10/2012DE102011084120A1 Photovoltaische Vorrichtung A photovoltaic device
05/10/2012CA2829117A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/10/2012CA2816219A1 Benzamides and nicotinamides as syk modulators
05/09/2012EP2450975A2 Compound for organic optoelectronic device and organic light emitting diode including the same
05/09/2012EP2448945A1 Crystalline forms of prasugrel salts
05/09/2012EP1651646B1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i
05/09/2012CN102448964A New spiroheterocyclic furan and thiofuran dione derivatives
05/09/2012CN102448933A Indole derivatives
05/09/2012CN102443010A Method for preparing amorphous clopidogrel hydrogen sulfate
05/09/2012CN102443009A Fused ring kinase inhibitor
05/09/2012CN102442993A Compounds and derivates thereof having dibenzyl groups, and preparation method and application thereof
05/09/2012CN102002055B Clean synthesis method for 3,4-ethylenedioxythiophene
05/09/2012CN101974015B Ester compound and preparation method and application thereof
05/09/2012CN101838275B Method for synthesizing 6-methyl-dibenzothienophridine
05/09/2012CN101830911B Thienopyridine derivatives, preparation method and application thereof
05/09/2012CN101468999B New polymorphs of olanzapine hydrochloride
05/08/2012US8173646 FAB I inhibitors
05/08/2012US8173636 Hydroxylthienoquinolones and related compounds as anti-infective agents
05/08/2012CA2631664C 9-membered heterobicyclic compounds as inhibitors of protein kinases
05/03/2012WO2012058209A1 Organic electronic devices, including organic photovoltaic devices, polymers, and monomers
05/03/2012WO2012055018A1 Therapeutic compositions for diabetic symmetrical polyneuropathy
05/03/2012WO2012003919A3 Semiconducting polymers
05/03/2012WO2011162515A3 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
05/03/2012US20120108813 Fused pyrimidineone compounds as trpv3 modulators
05/03/2012US20120108581 Fused piperidine compound and pharmaceutical containing same
05/03/2012US20120108562 Therapeutic compositions and methods
05/03/2012US20120107835 Method for detecting beta-amyloid using amino acid dimers
05/03/2012US20120107269 Thiophene derivatives
05/03/2012US20120104943 Material for organic electroluminescence device and organic electroluminescence device using the same
05/03/2012CA2804797A1 Therapeutic compositions for diabetic symmetrical polyneuropathy and/or tactile allodynia
05/02/2012EP2445916A1 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
05/02/2012EP1415992B1 Diamine derivatives
05/02/2012CN102439014A Biomolecular labelling using multifunctional biotin analogues
05/02/2012CN102432626A Synthesis method of 4,5,6,7-tetrahydrothiophene[3,2-c] pyridine hydrochloride
05/02/2012CN102432625A Crystallization method for preparing high-purity I-type clopidogrel hydrogen sulfate
05/02/2012CN102432624A Preparation technology for crystal of dithiole pyrrolones compound
05/01/2012US8168671 Synthesis of thieno[3,4-b]thiophene, thieno[3,4-b]furan, related compounds and their derivatives and use thereof
05/01/2012US8168641 Aspartyl protease inhibitors
05/01/2012CA2556669C Hepatitis c inhibitor peptide analogs
04/2012
04/26/2012WO2012054535A2 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012WO2012052843A1 Pochoxime conjugates useful for the treatment of hsp90 related pathologies
04/26/2012WO2012052788A1 Method for preparing pharmaceutically active ingredient and intermediates thereof
04/26/2012WO2012051667A1 Organic electroluminescent device
04/26/2012WO2011115435A3 Thiol derivative of biotin, and analysis method of substrate specificity of serine/threonine kinase using same
04/26/2012US20120101101 Therapeutic agent for motor disorders
04/26/2012US20120101095 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
04/26/2012US20120097935 Polycyclic dithiophenes
04/26/2012CA2813994A1 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012CA2812320A1 Pochoxime conjugates useful for the treatment of hsp90 related pathologies
04/25/2012EP2444807A2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use
04/25/2012EP2247586B1 2-aza-bicyclo[2.2.1]heptane derivatives
04/25/2012EP1565436B1 3-aminopyrrolidine derivatives as modulators of chemokine receptors
04/25/2012CN102424686A Process for production of prasugrel hydrochloride having high purity
04/25/2012CN102002056B 一种普拉格雷中间体的制备方法 A method of preparing intermediates prasugrel
04/25/2012CN101985451B 普拉格雷中间体的制备方法 Preparation prasugrel intermediates
04/25/2012CN101775025B New preparation method of Prasugrel
04/25/2012CN101747339B 1′-硫代氮杂靛玉红类化合物、用途及其制备方法 1'-aza Indirubin thiosulfate compounds, uses its preparation method
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 214